Tjoapack receives investment from Ampersand Capital Partners

In this Day in the Life of interview, Thomas Hauser, Director of Business Development at Tjoapack. Thomas has spent nearly 30 years in the pharmaceutical industry and describes how he still finds curiosity and excitement in the bigger picture of global health. 

 

Tjoapack expands sterile packaging & cold chain capacity in US/EU, adding new vial, auto-injector & PFS lines to better serve global biologics demand.

In this written panel discussion experts in the pharmaceutical packaging industry comment on the current state of sustainability in packaging, and what can be done to improve this in the future.

At Pharmapack Europe 2023, we spoke to some of our exhibitors about the products they were showcasing at this year's event, and asked for their insights into the packaging market for the year ahead. 

At Tjoapack we're dedicated to shaping the future of the pharmaceutical supply chain which is why we're delighted to announce that over the next two years we'll be expanding our facility in Etten-Leur from 8,400sq.m. to 11,500 sq.m.

The investment of over €10m will more than double our primary packaging capacity for oral solids, as well as bolster our warehousing and cold chain capabilities to meet demand for our value-added logistics services.

Read more here

At Tjoapack we’re committed to ensuring we consistently bolster our offering and deliver the efficient and flexible services that our clients expect.

That is why we are excited to announce our most recent investment into our automated injectables packaging capabilities which will begin operations in 2021!

Learn more about our current syringe and vial packaging offerings here

Postponement packaging is the practice of keeping products in a semi-finished, market agnostic state, and only finalising them when there is a specific market demand.

Used strategically, it will allow pharmaceutical manufacturers to respond to market-related fluctuation as well as variations in packaging requirements. In addition, postponement will enable pharma companies to lower working capital by reducing finished goods inventories, avoid repackaging work, reduce waste across the supply chain, and shorten their return on investment cycle.

In this whitepaper, Dr Anita Paz, Innovation Consultant and Dexter Tjoa, CEO (formerly Director Corporate Strategy) at Tjoapack, outline the postponement packaging principle and the key points to consider before implementing it as a supply chain strategy. They also discuss how this approach can be applied to different product portfolios and the benefits that adoption could bring to the pharmaceutical industry.

For more information on postponement packaging visit

Challenge us...